CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome: Carriers of pathogenic CDH1 mutations from HDGC families have a ~ 70% lifetime risk of developing advanced DGC and female carriers have an additional ~ 40% risk of LBC [5, 6].